Sign in now to see personalised content appear here.
You can also see your reading history and subscription details on your subscriber page.
The antibodies target an overexpressed protein on the surface of some cancer cells, which is not expressed on healthy cells
The one-step C-LiNK coupling technology will open up the development space for ADCs and represents a competitive alternative to other similar technologies
Alliance will provide an efficient end-to-end solution for the development and manufacture of ADCs
The shift from small molecules to large molecules, such as antibodies and proteins, has created new opportunities in the pharmaceutical industry
Agreement combines BioAtla's conditionally active biologic (CAB) antibodies with Pfizer's proprietary ADC payloads
To help improve productivity and simplify the purification process
Detailed validation protocols streamline optimisation and validation, saving time and reagents